High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 294 participants.
Also called NCT02534155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 294 participants
- Sponsor
- Registry
-
NCT02534155
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Italy, Switzerland
- Registry status
- Terminated
Technical summary
Registry record NCT02534155. Randomized; no masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High and Intermediate Risk Degenerative Mitral Regurgitation Treatment: A Trial Comparing MitraClip® to Surgical Therapy
- Acronym
- HiRiDe
- Condition
- Mitral Valve Insufficiency
- Intervention (Device)
- MitraClip®
- Intervention (Procedure)
- Mitral valve Surgery
- Lead sponsor
- University of Zurich
Record details
- Record id
cardio:ct-nct02534155- Content hash
da17f06cb03abf7c940d9596b55a5a407fb03a027d57bd30c3ab7768783fab13